Accordingly, the application of AKT inhibitors in conjunction with other therapeutic modalities, including chemotherapy, hormone therapy, radiotherapy, and immunotherapy, holds great promise in overcoming tumor resistance [37, 60, 61]. The gene discussed is AKT1; the disease is neoplasm.